Ellevest Inc’s Nuvalent NUVL Stock Holding History

Ellevest Inc’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9	Closed	-$268	–	2015
2022 Q4	$268	Buy	+9	New	+$251	﹤0.01%	1700

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Ellevest Inc's NUVL Position: Q1 2023 in Review

Ellevest Inc sold out of Nuvalent (NUVL) in Q1 2023, closing a stake of 9 shares — an estimated $268 sold.

Ellevest Inc first reported a position in NUVL in Q4 2022 and held it in 1 quarter. The position peaked at $268 in Q4 2022. 89 funds tracked by Wall St. Rank hold NUVL as of Q1 2023.

Ellevest Inc reported no remaining Nuvalent position as of Q1 2023 after selling out during the quarter.
Ellevest Inc sold 9 Nuvalent shares in Q1 2023, an estimated $268.
Ellevest Inc first reported a position in Nuvalent in Q4 2022 and held it in 1 quarter.
Ellevest Inc's Nuvalent position peaked at $268 in Q4 2022.
89 funds tracked by Wall St. Rank held Nuvalent as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.